Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension

PHASE4CompletedINTERVENTIONAL

Enrollment

167

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

March 31, 2007

Conditions

Hypertriglyceridemia

Interventions

DRUG

Antara (fenofibrate) + Lovaza

Antara (fenofibrate) + Lovaza (omega-3-acid ethyl esters) \[formerly known as Omacor\]

DRUG

Antara (fenofibrate)

Antara (fenofibrate) + placebo